Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IP licensing companies have greater opportunities

IP licensing companies have greater opportunities

posted on Jun 09, 2007 02:14PM

"IP licensing companies have greater opportunities for sustained growth and success if they have multiple resources of IP to tap into," said Morry Marshall, vice president of Semico. "The combination of Patriot's legacy technologies developed in-house and its jointly owned portfolio with TPL Group leave it well positioned for the future."

"The MMP Portfolio is only one element of the multifaceted Patriot Scientific story and business strategy," said Jim Turley, independent analyst and member of the Patriot Scientific board of directors. "The licensing revenues from the MMP Portfolio provide the company with a strong foundation so it can explore the multiple options available for its next stage of growth and development."

http://www.semico.com/mediacov/sep06/SemicoMediaCoverage_09-20-06_PatriotScientific-PRNewswire.pdf

Share
New Message
Please login to post a reply